Prot# SG035-0004: A Pivotal Study of SGN-35 in Treatment of Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma (ALCL)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/30/096/30/12

Funding

  • Seattle Genetics, Inc. (SG035-0004)